2 news items
FibroGen Reports First Quarter 2024 Financial Results
FGEN
6 May 24
, although some forward-looking statements are expressed differently. FibroGen's actual results may differ materially from those indicated in these forward
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
FGEN
2 Apr 24
. FibroGen's actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related
- Prev
- 1
- Next